Difference between revisions of "Cisplatin (Platinol)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead") |
m |
||
| Line 14: | Line 14: | ||
*[[Bone sarcoma]] | *[[Bone sarcoma]] | ||
*[[Breast cancer]] | *[[Breast cancer]] | ||
| − | |||
*[[Cervical cancer]] | *[[Cervical cancer]] | ||
*[[Diffuse large B-cell lymphoma]] | *[[Diffuse large B-cell lymphoma]] | ||
| Line 23: | Line 22: | ||
*[[Hepatobiliary cancer]] | *[[Hepatobiliary cancer]] | ||
*[[Hodgkin lymphoma]] | *[[Hodgkin lymphoma]] | ||
| + | *[[Low-grade glioma]] | ||
*[[Mantle cell lymphoma]] | *[[Mantle cell lymphoma]] | ||
*[[Melanoma]] | *[[Melanoma]] | ||
| Line 106: | Line 106: | ||
|Cisplatino Labinca | |Cisplatino Labinca | ||
|Cisplatino Martian | |Cisplatino Martian | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|- | |- | ||
|Cisplatinum | |Cisplatinum | ||
| Line 205: | Line 196: | ||
[[Category:Breast cancer medications]] | [[Category:Breast cancer medications]] | ||
[[Category:Cancer of unknown primary medications]] | [[Category:Cancer of unknown primary medications]] | ||
| − | |||
[[Category:Cervical cancer medications]] | [[Category:Cervical cancer medications]] | ||
[[Category:Diffuse large B-cell lymphoma medications]] | [[Category:Diffuse large B-cell lymphoma medications]] | ||
| Line 214: | Line 204: | ||
[[Category:Hepatobiliary cancer medications]] | [[Category:Hepatobiliary cancer medications]] | ||
[[Category:Hodgkin lymphoma medications]] | [[Category:Hodgkin lymphoma medications]] | ||
| + | [[Category:Low-grade glioma medications]] | ||
[[Category:Mantle cell lymphoma medications]] | [[Category:Mantle cell lymphoma medications]] | ||
[[Category:Melanoma medications]] | [[Category:Melanoma medications]] | ||
Revision as of 16:10, 20 January 2018
General information
Class/mechanism: Platinum analog, alkylating-like, producing predominantly interstrand DNA crosslinks that are cell-cycle nonspecific.[1][2]
Route: IV, intracavitary (intraperitoneal)
Extravasation: vesicant (concentration ≥0.5 mg/mL)/irritant (concentration <0.5 mg/mL)
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Anal cancer
- Anaplastic large cell lymphoma
- Basal cell carcinoma (BCC)
- Bladder cancer
- Bone sarcoma
- Breast cancer
- Cervical cancer
- Diffuse large B-cell lymphoma
- Esophageal cancer
- Extranodal NK/T-cell lymphoma, nasal type
- Gastric cancer
- Head and neck cancer
- Hepatobiliary cancer
- Hodgkin lymphoma
- Low-grade glioma
- Mantle cell lymphoma
- Melanoma
- Mesothelioma
- Multiple myeloma
- Neuroendocrine tumors
- Non-small cell lung cancer
- Ovarian cancer
- Pancreatic cancer
- Penile cancer
- Peripheral T-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Small cell lung cancer
- Testicular cancer
- Thymoma
- Transformed lymphoma
- Unknown primary
- Uterine cancer
Patient drug information
- Cisplatin (Platinol) patient drug information (Chemocare)[3]
- Cisplatin (Platinol) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 12/19/1978: Initial FDA approval
Also known as
| Synonyms | |||||||
|---|---|---|---|---|---|---|---|
| Abiplatin | Axiplat | Biocisplatinum | Bioplatino | Blastolem | Blastolem RU | Briplatin | Brisplatin |
| C-Platin | CDDP | Ceplatin | Ciplatan | Ciplexal | cis-diamminedichloroplatinum III | CIS-GRY | cis-platinum |
| Cismaplat | Cispatin | Cisplamerck | Cisplan | Cisplasol | Cisplatex | Cisplatin-AQ | Cisplatin-Ebewe I.A. |
| Cisplatin-Teva | Cisplatin Comp | Cisplatin DBL | Cisplatine | Cisplatin Ebewe | Cisplatine Cytosafe | Cisplatine Dakota | Cisplatine Merck |
| Cisplatine Teva | Cisplatin FOT | Cisplatin Hexal | Cisplatin Lederle | Cisplatin Lens | Cisplatin Maruko | Cisplatin Mayne | Cisplatin NC |
| Cisplatino | Cisplatino Almirall | Cisplatino Asofarm | Cisplatino Deltafarma | Cisplatino Ferrer | Cisplatino Gador | Cisplatino Labinca | Cisplatino Martian |
| Cisplatinum | Cisplatyl | Cisteen | Citoplatino | Cytoplatin | Cytoplatin-AQ | DACP | DDP |
| Docistin | Elvecis | Fauldcispla | IA COR | Ifapla | JIN Shun | Kemoplat | Lederplatin |
| Lyoph.cisplatin | Metaplatin | Neoplat | Neoplatin | Nippon Kayaku Cisplatin | Noveldexis | NSC 119875 | NUO XIN |
| Oncoplatin AQ | P&U Cisplatin | Placis | Platamin | Platamine | Platamine RTU | Platiblastin | Platiblastin-S |
| Platicis | Platidiam | Platikem | Platil | Platimit | Platin | Platinil | Platino II Filaxis |
| Platinol | Platinol AQ | Platinox | Platinoxan | platinum | Platiran | Platistil | Platistin |
| Platistine | Platosin | Pronto Platamine | Randa | Romcis | Shun KE DA | Sicatem | Sinplatin |
| Sisplanil | Tecnoplatin | Tisplal | Trav Cisplatin | Unistin | |||
References
Categories:
- Drug index
- Intravenous medications
- Intracavitary medications
- Vesicant chemotherapy
- Irritant chemotherapy
- Platinum agents
- Alkylating agents
- Anal cancer medications
- Anaplastic large cell lymphoma medications
- Basal cell carcinoma (BCC) medications
- Bladder cancer medications
- Bone sarcoma medications
- Breast cancer medications
- Cancer of unknown primary medications
- Cervical cancer medications
- Diffuse large B-cell lymphoma medications
- Esophageal cancer medications
- Extranodal NK/T-cell lymphoma, nasal type medications
- Gastric cancer medications
- Head and neck cancer medications
- Hepatobiliary cancer medications
- Hodgkin lymphoma medications
- Low-grade glioma medications
- Mantle cell lymphoma medications
- Melanoma medications
- Mesothelioma medications
- Multiple myeloma medications
- Neuroendocrine tumor medications
- Non-small cell lung cancer medications
- Ovarian cancer medications
- Pancreatic cancer medications
- Penile cancer medications
- Peripheral T-cell lymphoma medications
- Primary mediastinal B-cell lymphoma medications
- Small cell lung cancer medications
- Testicular cancer medications
- Thymoma medications
- Transformed lymphoma medications
- Uterine cancer medications
- Drugs FDA approved in 1978
- WHO Essential Cancer Medicine